Preventive Care in Type 2 Diabetes: Results of a Randomized, Controlled Trial in Community Pharmacies
Diabetes Care
.
2021 Aug;44(8):e157-e159.
doi: 10.2337/dc20-2319.
Epub 2021 Jun 30.
Authors
Katja Prax
1
,
Karin Schmiedel
2
,
Tobias Hepp
3
,
Helmut Schlager
4
,
Kristina Friedland
5
6
Affiliations
1
Molecular & Clinical Pharmacy, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
2
Kur-Apotheke, Bad Windsheim, Germany.
3
Institute of Medical Informatics, Biometry and Epidemiology, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
4
Scientific Institute for Prevention in Health Care, Munich, Germany.
5
Molecular & Clinical Pharmacy, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany
[email protected]
.
6
Pharmacology and Toxicology, Institute of Pharmacy and Biomedical Sciences, Johannes-Gutenberg-University Mainz, Mainz, Germany.
PMID:
34193436
DOI:
10.2337/dc20-2319
No abstract available
Publication types
Letter
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
MeSH terms
Community Pharmacy Services*
Diabetes Mellitus, Type 2* / prevention & control
Humans
Medication Adherence
Pharmacies*
Pharmacists
Associated data
DRKS/DRKS00013321